Header Logo

Connection

Richard Seist to Receptor, EphA1

Back to Details
This is a "connection" page, showing publications Richard Seist has written about Receptor, EphA1.
Richard Seist
Connection Strength
0.045
Receptor, EphA1
  1. Combination therapy with mTOR kinase inhibitor and dasatinib as a novel therapeutic strategy for vestibular schwannoma. Sci Rep. 2020 03 06; 10(1):4211.
    View in: PubMed
    Score: 0.045
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.